Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase
Authors:
- 1 June 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 67 (11) , 2081-2091
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The Antidiabetic Drug Metformin Activates the AMP-Activated Protein Kinase Cascade via an Adenine Nucleotide-Independent MechanismDiabetes, 2002
- Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 DiabetesDiabetes, 2002
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysJournal of Biological Chemistry, 2002
- Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain functionBiochemical Pharmacology, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chainBiochemical Journal, 2000
- Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex IJournal of Biological Chemistry, 2000
- The Antihyperglycaemic Effect of MetforminDrugs, 1999
- The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes.Endocrinology, 1996
- Preclinical Pharmacology of Biguanides1996